Difference between revisions of "Pirarubicin (THP)"
Jump to navigation
Jump to search
m |
m |
||
(6 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | '' | + | ''Approved for use in a number of countries; not the US.'' |
+ | ==Diseases for which it is used== | ||
+ | *[[Diffuse large B-cell lymphoma]] | ||
+ | *[[Upper tract urothelial carcinoma]] | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Code name:''' 1609-RB | ||
+ | *'''Generic name:''' theprubicin, THP-doxorubicin | ||
+ | *'''Brand names:''' Pinorubicin, Pinorubin, Therarubicin | ||
− | + | [[Category:Drugs]] | |
− | + | [[Category:Intravenous medications]] | |
+ | [[Category:Intravesical medications]] | ||
− | |||
− | |||
[[Category:Anthracyclines]] | [[Category:Anthracyclines]] | ||
+ | |||
+ | [[Category:Diffuse large B-cell lymphoma medications]] | ||
+ | [[Category:Upper tract urothelial carcinoma medications]] |
Latest revision as of 19:37, 28 December 2023
Approved for use in a number of countries; not the US.
Diseases for which it is used
Also known as
- Code name: 1609-RB
- Generic name: theprubicin, THP-doxorubicin
- Brand names: Pinorubicin, Pinorubin, Therarubicin